Department of Medicine and Surgery, University of Milano-Bicocca, Clinical Proteomics and Metabolomics Unit, 20854 Vedano al Lambro, Italy.
Int J Mol Sci. 2017 Dec 1;18(12):2588. doi: 10.3390/ijms18122588.
Gastric cancer (GC) is one of the leading causes of cancer-related deaths worldwide and the disease outcome commonly depends upon the tumour stage at the time of diagnosis. However, this cancer can often be asymptomatic during the early stages and remain undetected until the later stages of tumour development, having a significant impact on patient prognosis. However, our comprehension of the mechanisms underlying the development of gastric malignancies is still lacking. For these reasons, the search for new diagnostic and prognostic markers for gastric cancer is an ongoing pursuit. Modern mass spectrometry imaging (MSI) techniques, in particular matrix-assisted laser desorption/ionisation (MALDI), have emerged as a plausible tool in clinical pathology as a whole. More specifically, MALDI-MSI is being increasingly employed in the study of gastric cancer and has already elucidated some important disease checkpoints that may help us to better understand the molecular mechanisms underpinning this aggressive cancer. Here we report the state of the art of MALDI-MSI approaches, ranging from sample preparation to statistical analysis, and provide a complete review of the key findings that have been reported in the literature thus far.
胃癌(GC)是全球癌症相关死亡的主要原因之一,疾病的结局通常取决于诊断时的肿瘤分期。然而,这种癌症在早期通常没有症状,直到肿瘤发展的后期才被发现,这对患者的预后有重大影响。然而,我们对胃癌发展背后的机制的理解仍然不足。出于这些原因,寻找新的胃癌诊断和预后标志物是一个持续的追求。现代质谱成像(MSI)技术,特别是基质辅助激光解吸/电离(MALDI),已经成为整个临床病理学中一种可行的工具。更具体地说,MALDI-MSI 越来越多地被用于胃癌的研究,并已经阐明了一些重要的疾病检查点,这可能有助于我们更好地理解这种侵袭性癌症的分子机制。在这里,我们报告了 MALDI-MSI 方法的最新进展,从样品制备到统计分析,并对迄今为止文献中报道的关键发现进行了全面回顾。